Clinical Trial Update: Study Of RV-39 In Patients Who Also Have Asthma [Phase 4]

View source ↗

Summary

A Phase 4 trial of RV-39 in patients with asthma was terminated, with results posted in August 2009 by sponsor GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• RV-39

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: TERMINATED | Results posted: 2009-08-17